|
|
|
|
|
In this segment of the Drug Delivery Leader Live online event, Innovations In Drug Delivery: Opportunities For Enhancing Familiar, Mature Approaches, Courtney Evans, principal consultant at delivery device consultancy Suttons Creek and formerly at FDA, discusses regulatory implications of the integration or compatibility of digital applications with autoinjectors, combination products, and other drug delivery devices. |
|
|
|
By Bryan Mazlish, CEO, Surf Bio | Once dominated by IV infusions administered in hospital settings, the biologics industry is now at a crossroads. Here's why the future of biologics delivery is high-concentration subcutaneous injectables. | |
|
|
|
| Derisking APIs For Delivery Without Nitrosamine Impurities | White Paper | By Jason Brown, Adare Pharma Solutions | Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance. |
|
|
|
|
| Flexible Approaches To Autoinjector Assembly | Article | By Mads Keinicke Hansen, Stevanato Group | Explore how a flexible, scalable, and efficient solution for the assembly of autoinjectors can help you stay ahead of the competition and meet the demands of an ever-changing industry. |
|
|
|
|
|
.png){kind=logo}
